Literature DB >> 21243243

Restless legs syndrome in Parkinson's disease: clinical characteristics and biochemical correlations.

Tiago Machado Guerreiro1, Danilo Ryuko Cândido Nishikawa, Lis Campos Ferreira, Hyder Aragão de Melo, Roberto César Pereira do Prado.   

Abstract

Restless legs syndrome (RLS) is a neurological disorder that responds to dopaminergic drugs, indicating a common pathophysiology with Parkinson's disease (PD). The prevalence of RLS was estimated in a group of PD patients and its clinical and biochemical characteristics were analysed. Forty-eight patients with PD were evaluated into two groups, with and without RLS. Clinical characteristics assessed in both groups were age, gender, duration of PD, Hoehn and Yahr, and Schwab and England scales. Laboratory variables such as hemoglobin, s-iron, s-ferritin and creatinine were obtained. The prevalence of RLS was 18.75%. No significant differences regarding clinical variables and biochemical parameters were observed. The high prevalence of RLS found in PD patients suggests the concept of a common etiological link and it seems that secondary causes did not play a central role in the pathophysiology of RLS in this group of parkinsonian patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21243243     DOI: 10.1590/s0004-282x2010000600007

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  7 in total

1.  Restless leg syndrome and multiple sclerosis: a case-control study in China.

Authors:  Gangqiong Liu; Xiao Feng; Chao Lan; Ziqiang Zhu; Shengli Ma; Yu Guo; Rui Xue
Journal:  Sleep Breath       Date:  2015-05-24       Impact factor: 2.816

2.  A long-term prospective follow-up study of incident RLS in the course of chronic DAergic therapy in newly diagnosed untreated patients with Parkinson's disease.

Authors:  Stefano Calzetti; Monica Angelini; Anna Negrotti; Elena Marchesi; Matteo Goldoni
Journal:  J Neural Transm (Vienna)       Date:  2013-12-20       Impact factor: 3.575

3.  Restless legs syndrome in Iranian patients with multiple sclerosis.

Authors:  Shahnaz Miri; Mohammad Rohani; Mohammad Ali Sahraian; Babak Zamani; Gholam Ali Shahidi; Amin Sabet; Maziar Moradi-Lakeh; Mohammad Bodaghabadi
Journal:  Neurol Sci       Date:  2012-09-09       Impact factor: 3.307

4.  Linking restless legs syndrome with Parkinson's disease: clinical, imaging and genetic evidence.

Authors:  Tasneem Peeraully; Eng-King Tan
Journal:  Transl Neurodegener       Date:  2012-02-27       Impact factor: 8.014

5.  Repetitive Transcranial Magnetic Stimulation for the Treatment of Restless Legs Syndrome.

Authors:  Yi-Cong Lin; Yang Feng; Shu-Qin Zhan; Ning Li; Yan Ding; Yue Hou; Li Wang; Hua Lin; Ying Sun; Zhao-Yang Huang; Qing Xue; Yu-Ping Wang
Journal:  Chin Med J (Engl)       Date:  2015-07-05       Impact factor: 2.628

6.  Serum Ferritin Levels in Parkinson's Disease Patients with and without Restless Legs Syndrome.

Authors:  Maria-Lucia Muntean; Friederike Sixel-Döring; Claudia Trenkwalder
Journal:  Mov Disord Clin Pract       Date:  2015-06-04

Review 7.  Restless Legs Syndrome and Parkinson Disease: A Causal Relationship Between the Two Disorders?

Authors:  Luigi Ferini-Strambi; Giulia Carli; Francesca Casoni; Andrea Galbiati
Journal:  Front Neurol       Date:  2018-07-24       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.